I am also proud of this work that’s been driven by Mike. A really multi disciplinary group using ethical and legal frameworks to go through real world scenarios that are faced by researchers working with people living with dementia. Dementia Researcher Alzheimer's Society For Researchers Research at ARUK

ALZHEIMER'S DRUG PROPOSALS WANTED!! I'm delighted that National Institute for Health and Care Research are funding development of a UK platform trial for people with symptomatic AD. This is a partnership between MRC Clinical Trials Unit at UCL & Dementias Platform UK + many others, & supported by Research at ARUK Alzheimer's Society UK Dementia Research Institute. Please RT!

We co-founded the ACORD collaboration with UCL Queen Square Institute of Neurology & The University of Edinburgh, marking a new era for #ClinicalTrials in neurodegenerative diseases. In our '25 at 25' series, learn how this ambitious project offers new hope for people affected by these conditions. 👉 bit.ly/4caW1JM

More than 1 million people in the UK alone are living with a neurodegenerative condition. Learn more about the ACORD collaboration, which brings together researchers to identify new treatments which can slow, stop, or even reverse the progression of neurodegenerative diseases.👇

Was a pleasure to attend the PUMA launch event in London yesterday! Thank you to all those who attended and I had the opportunity to talk to.

Dr Sarah McCann introducing the Communities for Open Research Synthesis (COReS) project FENS Find out more 👉 cores-hub.io

The official end of my student discounts era (and in VAR slow-mo ICYMI 😅) thanks to all who’ve made the PhD possible, and for making it an incredibly fulfilling one with plenty of fun. Malcolm Macleod #FBPE CAMARADES ClinicalBrainScience Euan MacDonald Centre Anne Rowling Regenerative Neurology Clinic

Rob and I had discussed that the story of The rugby legend and his Indian neurologist would surely positively impact race relations🌺To all those with anger within, irrespective of colour/ religion etc: just take a deep breath, go home to your loved ones..life is too short…🧡

⏳With a closing date of 6th Sept there's time to apply to be part of a world-class team MND-SMART. MND-SMART is the UK's largest clinical trial for pplwMND with 22 sites across all 4 nations. #MND #ALS #MND_Research #Clinical_Trials #excellence ➡️edin.ac/4dHQmLR

It is with immense sorrow that we are sharing the sad news that Euan MacDonald died today. Euan was an extraordinary man who brought hope and helped transform the lives of countless people living with MND & other disabilities. euanmacdonaldcentre.org/about/news/mes…

Sad but also kind of funny: a list of 500+ papers whose authors obviously used ChatGPT to write their papers, and didn't even bother to remove obvious signs such as "As of my last knowledge update" or "As an AI language model" (!!) h/t Retraction Watch academ-ai.info/#category=

10 days left! Apply at edinburghneuroscience.ed.ac.uk/project/dement…

Safety and efficacy of memantine and trazodone versus placebo for motor neuron disease (MND SMART): stage two interim analysis from the first cycle of a phase 3, multiarm, multistage, randomised, adaptive platform trial - The Lancet Neurology thelancet.com/journals/laneu…

At the MRC Clinical Trials Unit at UCL #ACORD Fellows Academy meeting in London this morning with Professor James Carpenter and Professor Suvankar Pal Learn more about #ACORD here mrcctu.ucl.ac.uk/our-research/n… #NeuroDegenerativeDiseases #MRCCTU #ICTM #UCL ICTM at UCL

✨CAMARADES are hiring! ✨ We are looking for a research assistant to work across a diverse range of exciting #metaresearch projects. Learn more and apply at: shorturl.at/PAo80

Exciting opportunity for a funded PhD studentship in data-driven drug repurposing in intracerebral haemorrhage! tinyurl.com/4fa76yxy Q&A: 12 Dec 1000 Apply by 13.01.25 CAMARADES Please share!

With recent events, I’ve decided to take the leap - shall keep this account only for dissemination purposes. See you across at Blue Sky: chariswong.bsky.social or LinkedIn 👋